Dirk Hines
Family Medicine · Cincinnati, OHNPI 1245286590
Payments from drug & device makers
Across 307 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$660
- Pfizer$457
- AstraZeneca$422
- Novo Nordisk$394
- Amgen$299
- Lilly USA, LLC$281
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,40299%
- Education$441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $660 |
| Pfizer | 37 | $457 |
| AstraZeneca | 8 | $422 |
| Novo Nordisk | 25 | $394 |
| Amgen(2 entities) | 18 | $299 |
| Lilly USA, LLC | 24 | $281 |
| GSK | 22 | $252 |
| Sanofi-aventis U.S. LLC | 15 | $212 |
| Boehringer Ingelheim | 15 | $208 |
| Johnson & Johnson | 20 | $206 |
| Exact Sciences | 7 | $124 |
| Amarin Pharma, Inc. | 7 | $117 |
| Novartis | 8 | $108 |
| Merck | 6 | $87 |
| Bayer | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
| Abbott | 1 | $55 |
| Phadia US Inc. | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Radius Health, Inc. | 3 | $38 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Sunovion Pharmaceuticals Inc. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $26 |
| Hikma Pharmaceuticals USA | 2 | $24 |
| Dexcom, Inc. | 2 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$119
How this compares
$4,445 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 26 | $27,936 |
| RybelsusSemaglutide | 14 | $21,112 |
| JardianceEmpagliflozin | 23 | $18,191 |
| OzempicSemaglutide | 14 | $17,257 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $16,452 |
| FarxigaDapagliflozin Propanediol | 16 | $14,737 |
| MyrbetriqMirabegron | 21 | $9,744 |
| VascepaIcosapent Ethyl | 11 | $6,085 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,104 |
| Atorvastatin Calcium | 134 | $1,180 |
| Pantoprazole Sodium | 57 | $973 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $909 |
| Gabapentin | 44 | $603 |
| Ipratropium Bromide | 14 | $590 |
| Diclofenac Sodium | 18 | $587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $394 | $38,36928 claims |
| Lilly USA, LLCMounjaro | $281 | $27,93626 claims |
| Boehringer IngelheimJardiance | $208 | $18,19123 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $212 | $16,45212 claims |
| AstraZenecaFarxiga | $422 | $14,73716 claims |
| Astellas Pharma US IncMyrbetriq | $34 | $9,74421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Cincinnati
- Michael ButcherCincinnati$18.3M
- Paul NugentCincinnati$4.9M
- Rajesh DavitCincinnati$2M
- Michael HeileCincinnati$272K
- Michael NossCincinnati$265K
- Amy MechleyCincinnati$120K
- Melissa SchroerCincinnati$116K
- William CoxCincinnati$52K
- Frank PerrinoCincinnati$49K
- Sean LyndCincinnati$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.